Zydus: Zydus Lifesciences Ltd announced that the US FDA has classified its injectable manufacturing unit at Pharmez SEZ, Matoda, as Official Action Indicated (OAI) following a March inspection. This means the site requires further administrative sanctions and mandatory corrective actions.